These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 1516067
1. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. Cancer Res; 1992 Sep 15; 52(18):5104-9. PubMed ID: 1516067 [Abstract] [Full Text] [Related]
2. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB. Cancer Res; 1993 Aug 01; 53(15):3585-90. PubMed ID: 8339265 [Abstract] [Full Text] [Related]
3. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Rubin MA, Mucci NR, Figurski J, Fecko A, Pienta KJ, Day ML. Hum Pathol; 2001 Jul 01; 32(7):690-7. PubMed ID: 11486167 [Abstract] [Full Text] [Related]
4. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Bussemakers MJ, van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM, Schalken JA. Cancer Res; 1992 May 15; 52(10):2916-22. PubMed ID: 1581909 [Abstract] [Full Text] [Related]
5. Cadherin switching in human prostate cancer progression. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, Schalken JA. Cancer Res; 2000 Jul 01; 60(13):3650-4. PubMed ID: 10910081 [Abstract] [Full Text] [Related]
6. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function. Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB. Cancer Res; 1995 Nov 01; 55(21):4813-7. PubMed ID: 7585512 [Abstract] [Full Text] [Related]
7. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA. Cancer Res; 1994 Jul 15; 54(14):3929-33. PubMed ID: 7518346 [Abstract] [Full Text] [Related]
8. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone. Saha B, Arase A, Imam SS, Tsao-Wei D, Naritoku WY, Groshen S, Jones LW, Imam SA. Prostate; 2008 Jan 01; 68(1):78-84. PubMed ID: 18008331 [Abstract] [Full Text] [Related]
9. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone. Saha B, Kaur P, Tsao-Wei D, Naritoku WY, Groshen S, Datar RH, Jones LW, Imam SA. Prostate; 2008 Nov 01; 68(15):1681-8. PubMed ID: 18712716 [Abstract] [Full Text] [Related]
10. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Richmond PJ, Karayiannakis AJ, Nagafuchi A, Kaisary AV, Pignatelli M. Cancer Res; 1997 Aug 01; 57(15):3189-93. PubMed ID: 9242448 [Abstract] [Full Text] [Related]
11. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. Rashid MG, Sanda MG, Vallorosi CJ, Rios-Doria J, Rubin MA, Day ML. Cancer Res; 2001 Jan 15; 61(2):489-92. PubMed ID: 11212238 [Abstract] [Full Text] [Related]
12. Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer. Musiał J, Sporny S, Nowicki A. Pol J Pathol; 2007 Jan 15; 58(4):235-43. PubMed ID: 18459457 [Abstract] [Full Text] [Related]
13. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. Jaggi M, Rao PS, Smith DJ, Wheelock MJ, Johnson KR, Hemstreet GP, Balaji KC. Cancer Res; 2005 Jan 15; 65(2):483-92. PubMed ID: 15695390 [Abstract] [Full Text] [Related]
14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K. Anticancer Res; 2005 Jan 15; 25(3A):1615-22. PubMed ID: 16033070 [Abstract] [Full Text] [Related]
15. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Song Y, Oda Y, Hori M, Kuroiwa K, Ono M, Hosoi F, Basaki Y, Tokunaga S, Kuwano M, Naito S, Tsuneyoshi M. Hum Pathol; 2010 Feb 15; 41(2):214-22. PubMed ID: 19800102 [Abstract] [Full Text] [Related]
16. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells. Dalrymple S, Antony L, Xu Y, Uzgare AR, Arnold JT, Savaugeot J, Sokoll LJ, De Marzo AM, Isaacs JT. Cancer Res; 2005 Oct 15; 65(20):9269-79. PubMed ID: 16230388 [Abstract] [Full Text] [Related]
17. E-cadherin expression correlates with tumor differentiation in colorectal cancer. Karatzas G, Karayiannakis AJ, Syrigos KN, Chatzigianni E, Papanikolaou S, Riza F, Papanikolaou D. Hepatogastroenterology; 1999 Oct 15; 46(25):232-5. PubMed ID: 10228798 [Abstract] [Full Text] [Related]
18. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. Horvath LG, Lelliott JE, Kench JG, Lee CS, Williams ED, Saunders DN, Grygiel JJ, Sutherland RL, Henshall SM. Prostate; 2007 Jul 01; 67(10):1081-90. PubMed ID: 17476687 [Abstract] [Full Text] [Related]
19. [Correlation and significance of E-cadherin and N-cadherin expression in prostate cancer]. Huang X, Zhou LQ, Ai JK, Lu YQ, Bai Y, Zeng L, Zhang ZW, Guo YL. Ai Zheng; 2002 Nov 01; 21(11):1208-11. PubMed ID: 12526217 [Abstract] [Full Text] [Related]
20. Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells. Furbert-Harris PM, Parish-Gause D, Hunter KA, Vaughn TR, Howland C, Okomo-Awich J, Forrest K, Laniyan I, Abdelnaby A, Oredipe OA. Cell Mol Biol (Noisy-le-grand); 2003 Nov 01; 49(7):1009-16. PubMed ID: 14682382 [Abstract] [Full Text] [Related] Page: [Next] [New Search]